Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SBC to Revenue
135.10%
Quarterly · Period ending:
ARMP SBC to Revenue
Latest reported135.10%period ending
Latest reported135.10%period ending
ARMP Quarterly SBC/Revenue (0.00% → 135.10%)
Latest values, visible window
High-resolution chart · PNG
ARMP sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 135.0996% | |
| 136.2484% | |
| 0% | |
| 0% | |
| 26.5099% | |
| 159.0631% | |
| 28.664% | |
| 22.5362% | |
| 0% | |
| 55.2795% | |
| 12.6309% | |
| -30.449% | |
| 26.6327% | |
| 107.6633% | |
| 77.7355% | |
| 63.2287% | |
| 50.3983% | |
| 39.8867% | |
| 67.1385% | |
| 37.49% | |
| 77.6541% | |
| 78.9869% | |
| 171.0317% | |
| 230.2083% | |
| 2,922.5806% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 660% | |
| 257.8947% | |
| 1,067.8571% | |
| 589.6552% | |
| 1,350% | |
| 1,151.7241% | |
| 532.0388% | |
| 769.8113% | |
| 179.6875% | |
| 103.4965% | |
| 51.9608% | |
| 50.9804% | |
| 349.4949% | |
| 1,032.0388% | |
| 85.4839% | |
| 251.9231% | |
| -2,887.5% | |
| -8,266.6667% | |
| 256.051% | |
| 700% | |
| 2.2635% | |
| 2.32% | |
| 7.521% | |
| 32.0536% | |
| 0% | |
| 0% | |
| 7.7631% | |
| 30% | |
| 0% | |
| 0% | |
| 11.0777% | |
| 21.482% | |
| 0% | |
| 0% | |
| 9.0947% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1.5391% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |